Notes ON’s Steve Cornacchia, “Over the past several months, we found ourselves quickly pivoting alongside our clients in order to respond to market challenges the pandemic brought to the healthcare industry and the country. We moved into functions and spaces to help support clients that were suddenly in the epicenter of helping the nation, having to quickly ramp up to manufacture and distribute tests and initialize potential novel therapies to fight the virus. We also worked with clients whose businesses were suddenly heavily impacted by challenges to our hospital infrastructure and sidelining of the non-COVID related therapies, products and services that they market.”

Notes ON’s Suzanne Zebedee, Ph.D. about how the pandemic has impacted the sector, “Many clients have shared that they initiated new programs or pivoted from non-infectious disease programs to help with virus detection, therapeutics or vaccines. This brings a few advantages – one is to do their part to contribute scientifically to advance the science around the virus and disease and the second is to raise awareness of the company and platform technologies which will help when extended to other diseases.”

These expert consultants bring substantial recruiting and operating experience from the life sciences and healthcare industry. Their expertise strengthens our solid understanding of what creates successful, effective leaders in this highly regulated and demanding scientific space.

We have a successful track record of placing executives across a breadth of corporate, commercial, research, and development functions. We have experience recruiting for companies across all development stages from large multinationals to early-stage venture-backed companies, including the following sectors:

• Biotechnology
• Pharmaceutical
• Diagnostics / Life Sciences Tools
• Digital Health
• Medical Devices
• Healthcare Services